World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
45783
World Ranking
4966
National Ranking
2697

Overview

Val J. Lowe is affiliated with the Mayo Clinic in the United States. Their research primarily falls within the field of Medicine, with extensive work in several subfields including Psychiatry and Mental Health, Radiology, Nuclear Medicine and Imaging, Physiology, Neurology, and Cognitive Neuroscience.

Lowe's research topics cover a range of subjects related to brain health and neurodegenerative diseases. These include:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's Disease Research and Treatments
  • Advanced Neuroimaging Techniques and Applications
  • Functional Brain Connectivity Studies
  • Parkinson's Disease Mechanisms and Treatments
  • Medical Imaging Techniques and Applications
  • Neurobiology of Language and Bilingualism

Their scholarly output includes contributions to notable journals and publication venues such as:

  • Alzheimer's & Dementia
  • Neurology
  • Brain Communications
  • Brain
  • Neurobiology of Aging

Recent significant papers authored by or including Val J. Lowe are:

  • Performance of plasma phosphorylated tau 181 and 217 in the community, 2022, Nature Medicine
  • Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes, 2020, JAMA Neurology
  • Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research, 2021, Alzheimer's & Dementia
  • Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes, 2021, JAMA Neurology
  • Deep learning-based brain age prediction in normal aging and dementia, 2022, Nature Aging

Lowe collaborates frequently with a group of researchers including Clifford R. Jack, Ronald C. Petersen, David S. Knopman, Jonathan Graff-Radford, and Christopher G. Schwarz. These coauthors have worked extensively with Lowe across numerous studies, collectively advancing research on neurodegenerative diseases through clinical and imaging approaches.

Best Publications

  • Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

    Clifford R. Jack Jr.;Val J. Lowe;Stephen D Weigand;Heather J. Wiste

  • Recommendations on the Use of 18F-FDG PET in Oncology

    James W. Fletcher;James W. Fletcher;Benjamin Djulbegovic;Heloisa P. Soares;Barry A. Siegel

  • 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

    Clifford R. Jack;Val J. Lowe;Matthew L. Senjem;Stephen D. Weigand

  • Defining imaging biomarker cut points for brain aging and Alzheimer's disease

    Clifford R. Jack;Heather J. Wiste;Stephen D. Weigand;Terry M. Therneau

  • Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

    M.Akram Khan;Connie S Combs;Elizabeth M Brunt;Val J Lowe

  • Prospective investigation of positron emission tomography in lung nodules

    V. J. Lowe;J. W. Fletcher;L. Gobar;M. Lawson

  • Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

    E F Patz;V J Lowe;J M Hoffman;S S Paine

  • An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease

    Clifford R. Jack;David S. Knopman;Stephen D. Weigand;Heather J. Wiste

  • Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography.

    Michelle M. Mielke;Clinton E. Hagen;Jing Xu;Xiyun Chai

  • Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0.

    Ian Law;Nathalie L. Albert;Javier Arbizu;Ronald Boellaard;Ronald Boellaard

  • An autoradiographic evaluation of AV-1451 Tau PET in dementia.

    Val J. Lowe;Geoffry Curran;Ping Fang;Amanda M. Liesinger

  • Longitudinal tau PET in ageing and Alzheimer's disease.

    Clifford R Jack;Heather J Wiste;Christopher G Schwarz;Val J Lowe

  • Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech

    Keith Anthony Josephs;Joseph R Duffy;Edythe Strand;Mary Margaret Machulda

  • Brain β-amyloid load approaches a plateau

    Clifford R. Jack;Heather J. Wiste;Timothy G. Lesnick;Stephen D. Weigand

  • Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72

    Bradley F. Boeve;Kevin B. Boylan;Neill R. Graff-Radford;Mariely DeJesus-Hernandez

  • Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span

    Clifford R. Jack;Heather J. Wiste;Stephen D. Weigand;David S. Knopman

  • Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology

    Beatriz G. Perez-Nievas;Thor D. Stein;Hwan Ching Tai;Oriol Dols-Icardo

  • Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study

    Clifford R Jack;Heather J Wiste;Stephen D Weigand;Walter A Rocca

  • Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.

    V. J. Lowe;J. M. Hoffman;D. M. DeLong;E. F. Patz

  • Recommendations on the Use of 18 F-FDG PET in Oncology

    James W. Fletcher;Benjamin Djulbegovic;Heloisa P. Soares;Barry A. Siegel

Frequent Co-Authors

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in Medicine doesn’t always mean medical school. There are a range of alternative online degrees that can open rewarding healthcare career pathways. For those interested in healthcare leadership, earning a graduate-level degree, like a cahme accredited online mha programs list, offers valuable training in managing hospitals and clinics.

Registered nurses (RNs) looking to advance their credentials without traditional hurdles can explore the best online rn to bsn programs without clinical requirements. These programs allow working nurses to earn a BSN flexibly and completely online.

For nurses who aspire to hold advanced practice or leadership roles, a Doctor of Nursing Practice (DNP) can be the next step. There are options for those seeking a faster route, such as the shortest dnp program online and the shortest dnp program.

These degree options support career growth in healthcare without the need to attend campus full-time. If you’re exploring paths beyond traditional medical education, these online programs provide flexible alternatives tailored to your professional goals.

Best Scientists Citing Val J. Lowe

Trending Scientists